$1.580
-0.391 (-24.76%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
CELU Prediction & Forecast by Similar Chart Analysis
Alphio's CELU stock price prediction model matches the current Celularity Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.64 (+4.01%). The 1-week path is $1.66 (+5.00%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Celularity Inc Stock?
Celularity Inc is a good buy right now due to its recent price increase of 97.49% over the past five days and a current RSI of 67.467, indicating strong momentum. The partnership with MuseCell could potentially generate over $300 million in revenue over the next five years, which is a significant positive catalyst. However, the company faces risks due to its Nasdaq compliance issues, particularly the need to submit a compliance plan by September 4, 2026, which could impact its stock performance.
CELU stock price ended at $1.58 on Friday, after losing -24.76%
Celularity Inc (CELU) last closed at $1.58, losing -24.76%. These facts feed the 1-day and 1-week CELU price prediction above.
Forecast Drivers
Celularity Inc (CELU) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches CELU, ranked by similarity.
Seasonality analysis for CELU
Historically the probability of a positive August return for CELU is 65.08%. January offers the highest probability of a positive month at 68.85%, while December is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.